Abstract

Antibiotics are often used in the treatment of chronic periodontitis, which is a major cause of tooth loss. However, evidence in favour of a microbial indication for the prescription of antibiotics is lacking, which may increase the risk of the possible indiscriminate use of antibiotics, and consequent, microbial resistance. Here, using an open-ended technique, we report the changes in the subgingival microbiome up to one year post-treatment of patients treated with basic periodontal therapy with or without antibiotics. Antibiotics resulted in a greater influence on the microbiome 3 months after therapy, but this difference disappeared at 6 months. Greater microbial diversity, specific taxa and certain microbial co-occurrences at baseline and not the use of antibiotics predicted better clinical treatment outcomes. Our results demonstrate the predictive value of specific subgingival bacterial profiles for the decision to prescribe antibiotics in the treatment of periodontitis, but they also indicate the need for alternative therapies based on ecological approaches.

Highlights

  • Baseline 3 months 6 months 12 months Baseline 3 months 6 months 12 months Baseline 3 months 6 months 12 months Baseline 3 months 6 months 12 months

  • We investigated the subgingival microbiome of 37 subjects affected by chronic periodontitis who received standard non-surgical periodontal therapy and chlorhexidine rinses

  • This study investigated the effect of non-surgical periodontal therapy with or without antibiotic use on the subgingival microbiome

Read more

Summary

Introduction

The effects of the use of antibiotics together with non-surgical periodontal therapy on the composition of the subgingival microbiome has been widely investigated with targeted techniques such as anaerobic culturing[19], DNA hybridization[18,22], polymerase chain reaction[17,20] and micro-arrays[23]. These techniques are not able to investigate the composition of the microbial community in the manner that like open-ended techniques, such as 16S rDNA amplicon sequencing, are able to investigate[10,24]. Thereafter, we explored the microbial community compositions in relation to the clinical outcomes

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.